PharmaEngine recognized as one of 2025 Taiwan Best-in-Class Companies by Taiwan Institute of Directors

PharmaEngine announces TFDA approval of PEP08 Phase 1 clinical trial for solid tumor cancers

PharmaEngine announces Phase I clinical study of PEP08 has been approved by Australia HREC and acknowledged by Australia TGA